ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer - Centenera, MM; Scott, JS; Machiels, J; Nassar, ZD; Miller, DC; Zininos, I; Dehairs, J; Burvenich, IJG; Zadra, G; Chetta, P; Bango, C; Evergren, E; et al. (Cancer Research, 2021)